TABLE OF CONTENTS
|  | | | Volume 28, Issue 12 (December 2014) |  | In this issue
 Editorial
Spotlight Review
Review
Original Articles
Letters To The Editor
Reply To Letter To The Editor
Corrigenda
Also new
   AOP
| | | | | | Advertisement | | | NEW LAB OFFERS: Exclusive deals on equipment and services Save time and money, check Marketplace first VISIT MARKETPLACE TODAY |  | | | | | Editorial | Top | | Still no certainty about the role of upfront bortezomib among patients with AL amyloidosis A Dispenzieri Leukemia 2014 28: 2273-2275; 10.1038/leu.2014.271 Full Text | | Spotlight Review | Top | | Pre-leukemic evolution of hematopoietic stem cells: the importance of early mutations in leukemogenesis M R Corces-Zimmerman and R Majeti Leukemia 2014 28: 2276-2282; advance online publication, July 9, 2014; 10.1038/leu.2014.211 Abstract | Full Text | | Review | Top | | Next generation treatment of acute graft-versus-host disease J Magenau and P Reddy Leukemia 2014 28: 2283-2291; advance online publication, June 18, 2014; 10.1038/leu.2014.195 Abstract | Full Text | | Original Articles | Top | | Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status M Schmidt, J Rinke, V Schäfer, S Schnittger, A Kohlmann, E Obstfelder, C Kunert, J Ziermann, N Winkelmann, E Eigendorff, T Haferlach, C Haferlach, A Hochhaus and T Ernst Leukemia 2014 28: 2292-2299; advance online publication, September 12, 2014; 10.1038/leu.2014.272 Abstract | Full Text | | | | Calreticulin mutations and long-term survival in essential thrombocythemia A Tefferi, E A Wassie, T L Lasho, C Finke, A A Belachew, R P Ketterling, C A Hanson, A Pardanani, N Gangat and A P Wolanskyj Leukemia 2014 28: 2300-2303; advance online publication, May 5, 2014; 10.1038/leu.2014.148 Abstract | Full Text | | | | A matched comparison of cyclophosphamide, bortezomib and dexamethasone (CVD) versus risk-adapted cyclophosphamide, thalidomide and dexamethasone (CTD) in AL amyloidosis C P Venner, J D Gillmore, S Sachchithanantham, S Mahmood, T Lane, D Foard, L Rannigan, S D J Gibbs, J H Pinney, C J Whelan, H J Lachmann, P N Hawkins and A D Wechalekar Leukemia 2014 28: 2304-2310; advance online publication, July 16, 2014; 10.1038/leu.2014.218 Abstract | Full Text | | | | Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case–control study on 174 patients G Palladini, P Milani, A Foli, M Vidus Rosin, M Basset, F Lavatelli, M Nuvolone, L Obici, S Perlini and G Merlini Leukemia 2014 28: 2311-2316; advance online publication, July 25, 2014; 10.1038/leu.2014.227 Abstract | Full Text | | | | Risk of myeloid neoplasms after solid organ transplantation L M Morton, T M Gibson, C A Clarke, C F Lynch, L A Anderson, R Pfeiffer, O Landgren, D D Weisenburger and E A Engels Leukemia 2014 28: 2317-2323; advance online publication, April 14, 2014; 10.1038/leu.2014.132 Abstract | Full Text | | | | Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia V Kumar, R Palermo, C Talora, A F Campese, S Checquolo, D Bellavia, L Tottone, G Testa, E Miele, S Indraccolo, A Amadori, E Ferretti, A Gulino, A Vacca and I Screpanti Leukemia 2014 28: 2324-2335; advance online publication, April 14, 2014; 10.1038/leu.2014.133 Abstract | Full Text | | | | A revised definition for cure of childhood acute lymphoblastic leukemia C H Pui, D Pei, D Campana, C Cheng, J T Sandlund, W P Bowman, M M Hudson, R C Ribeiro, S C Raimondi, S Jeha, S C Howard, D Bhojwani, H Inaba, J E Rubnitz, M L Metzger, T A Gruber, E Coustan-Smith, J R Downing, W H Leung, M V Relling and W E Evans Leukemia 2014 28: 2336-2343; advance online publication, April 30, 2014; 10.1038/leu.2014.142 Abstract | Full Text | | | | Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients M Sakurai, H Kunimoto, N Watanabe, Y Fukuchi, S Yuasa, S Yamazaki, T Nishimura, K Sadahira, K Fukuda, H Okano, H Nakauchi, Y Morita, I Matsumura, K Kudo, E Ito, Y Ebihara, K Tsuji, Y Harada, H Harada, S Okamoto and H Nakajima Leukemia 2014 28: 2344-2354; advance online publication, April 15, 2014; 10.1038/leu.2014.136 Abstract | Full Text | | | | Therapeutic targeting of naturally presented myeloperoxidase-derived HLA peptide ligands on myeloid leukemia cells by TCR-transgenic T cells R Klar, S Schober, M Rami, S Mall, J Merl, S M Hauck, M Ueffing, A Admon, J Slotta-Huspenina, M Schwaiger, S Stevanović, R A J Oostendorp, D H Busch, C Peschel and A M Krackhardt Leukemia 2014 28: 2355-2366; advance online publication, April 16, 2014; 10.1038/leu.2014.131 Abstract | Full Text | | | | High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial D Rossille, M Gressier, D Damotte, D Maucort-Boulch, C Pangault, G Semana, S Le Gouill, C Haioun, K Tarte, T Lamy, N Milpied, T Fest and for the Groupe Ouest-Est des Leucémies et Autres Maladies du Sang Leukemia 2014 28: 2367-2375; advance online publication, April 15, 2014; 10.1038/leu.2014.137 Abstract | Full Text | | | | FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma L Sehgal, R Mathur, F K Braun, J F Wise, Z Berkova, S Neelapu, L W Kwak and F Samaniego Leukemia 2014 28: 2376-2387; advance online publication, April 3, 2014; 10.1038/leu.2014.126 Abstract | Full Text | | | | Mesenchymal stromal cells inhibit proliferation of virus-specific CD8+ T cells G Malcherek, N Jin, A G Hückelhoven, J Mani, L Wang, U Gern, A Diehlmann, P Wuchter, A Schmitt, B Chen, A D Ho and M Schmitt Leukemia 2014 28: 2388-2394; advance online publication, September 17, 2014; 10.1038/leu.2014.273 Abstract | Full Text | | Letters To The Editor | Top | | Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progression J Ojha, C Secreto, K Rabe, J Ayres-Silva, R Tschumper, D V Dyke, S Slager, R Fonseca, T Shanafelt, N Kay and E Braggio Leukemia 2014 28: 2395-2398; advance online publication, July 18, 2014; 10.1038/leu.2014.226 Full Text | | | | CD34+CD38−CD58− cells are leukemia-propagating cells in Philadelphia chromosome-positive acute lymphoblastic leukemia Y Kong, Y-J Chang, Y-R Liu, Y-Z Wang, Q Jiang, H Jiang, Y-Z Qin, Y Hu, Y-Y Lai, C-W Duan, D-L Hong and X-J Huang Leukemia 2014 28: 2398-2401; advance online publication, July 25, 2014; 10.1038/leu.2014.228 Full Text | | | | The prognostic importance of the presence of more than one focal lesion in spine MRI of patients with asymptomatic (smoldering) multiple myeloma E Kastritis, L A Moulopoulos, E Terpos, V Koutoulidis and M A Dimopoulos Leukemia 2014 28: 2402-2403; advance online publication, July 31, 2014; 10.1038/leu.2014.230 Full Text | | | | Primary acute myeloid leukemia cells with IDH1 or IDH2 mutations respond to a DOT1L inhibitor in vitro S M Sarkaria, M J Christopher, J M Klco and T J Ley Leukemia 2014 28: 2403-2406; advance online publication, July 31, 2014; 10.1038/leu.2014.235 Full Text | | | | Lymphodepletion followed by infusion of suicide gene-transduced donor lymphocytes to safely enhance their antitumor effect: a phase I/II study S Maury, M Rosenzwajg, R Redjoul, A Marcais, A Xhaard, M Cherai, L Cabanne, G Churlaud, F Suarez, G Socié, L Gregoire, K Debbache, C Bernard, J-L Beaumont, N Azar, O Boyer, F Roudot-Thoraval, J L Cohen, C Cordonnier, F M Lemoine and D Klatzmann Leukemia 2014 28: 2406-2410; advance online publication, August 8, 2014; 10.1038/leu.2014.237 Full Text | | | | Five gene probes carry most of the discriminatory power of the 70-gene risk model in multiple myeloma OPEN C J Heuck, P Qu, F van Rhee, S Waheed, S Z Usmani, J Epstein, Q Zhang, R Edmondson, A Hoering, J Crowley and B Barlogie Leukemia 2014 28: 2410-2413; advance online publication, July 31, 2014; 10.1038/leu.2014.232 Full Text | | | | Phase II study of pomalidomide in high-risk relapsed and refractory multiple myeloma S Z Usmani, Q Zhang, K Stratton, P Qu, S Yaccoby, E Hansen, D Steward, S Panozzo, N Petty, A Hoering, S Waheed, F Van Rhee, J Crowley and B Barlogie Leukemia 2014 28: 2413-2415; advance online publication, August 25, 2014; 10.1038/leu.2014.248 Full Text | | | | AKT-induced reactive oxygen species generate imatinib-resistant clones emerging from chronic myeloid leukemia progenitor cells M Nieborowska-Skorska, S Flis and T Skorski Leukemia 2014 28: 2416-2418; advance online publication, August 25, 2014; 10.1038/leu.2014.249 Full Text | | | | Relationship of different platelet response criteria and patient outcomes in a romiplostim myelodysplastic syndromes trial OPEN U Platzbecker, M A Sekeres, H Kantarjian, A Giagounidis, G J Mufti, C Jia, A S Yang and P Fenaux Leukemia 2014 28: 2418-2421; advance online publication, September 2, 2014; 10.1038/leu.2014.253 Full Text | | | | Early death in acute promyelocytic leukemia (APL) in French centers: a multicenter study in 399 patients R Rahmé, X Thomas, C Recher, N Vey, J Delaunay, E Deconinck, P Hirsch, D Bordessoule, J-B Micol, A Stamatoullas, C Mariette, C Pautas, P Bories, J-P Marolleau, M Hunault-Berger, N Fegueux, E Raffoux, H Dombret, L Degos, P Fenaux and L Adès Leukemia 2014 28: 2422-2424; advance online publication, August 21, 2014; 10.1038/leu.2014.240 Full Text | | Reply To Letter To The Editor | Top | | Prompt all-trans retinoic acid administration and early death in acute promyelocytic leukemia: what does the evidence say? A Rashidi and S I Fisher Leukemia 2014 28: 2425-2426; advance online publication, September 17, 2014; 10.1038/leu.2014.274 Full Text | | Corrigenda | Top | | Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia D Allegra, V Bilan, A Garding, M Zucknick, H Döhner, S Stilgenbauer, F Kuchenbauer and D Mertens Leukemia 2014 28: 2427; 10.1038/leu.2014.304 Full Text | | | | WTAP is a novel oncogenic protein in acute myeloid leukemia H Bansal, Q Yihua, S P Iyer, S Ganapathy, D A Proia, L O Penalva, P J Uren, U Suresh, J S Carew, A B Karnad, S Weitman, G E Tomlinson, M K Rao, S M Kornblau and S Bansal Leukemia 2014 28: 2427; 10.1038/leu.2014.290 Full Text | | | | |  | | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Leukemia. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | |
| |
No comments:
Post a Comment